FOR IMMEDIATE RELEASE
Orthomolecular Medicine News Service, November 14, 2024

Nutritional Pharmacology and Pharmaconutrients: Towards a Restorative and Synthesis Medicine

Juan Manuel Martinez Mendez, MD
Ortho-Regenerative Medicine Independent Researcher and Clinician
Email: info@drjuanmanuelmartinezm.com
Website: Dr. Juan Manuel Martinez Mendez

Introduction

This paper examines the paradigm of nutritional pharmacology, exploring its applications in clinical settings and comparing its efficacy with pharmaconutrients. By integrating these disciplines, this convergent approach aims to harness the benefits of both nutritional and pharmaconutrients therapies to achieve optimal outcomes for patients, healthcare providers, and their families.

Historical Emergence and Foundations

The term 'nutritional pharmacology' was first defined in 1980 by the late Dr. Gene A. Spiller, Ph.D., as "the link between the nutritional and pharmacological health sciences and the application of both to medicine," encompassing the pharmacological use of nutrients and other compounds derived from foods, both in natural form and as chemically modified. Dr. Jeffrey Bland, Ph.D., revisiting this concept 28 years later, provocatively stated, "As the field of nutrigenomics and nutritional epigenomics advances, it is likely that the concepts of Garrod, Williams, Pauling, and Hoffer will be found to be correct when nutritional pharmacology is applied to the right patient with the right dose of the right nutrient." Additionally, in The Future of Nutritional Pharmacology, Dr. Jeffrey Bland emphasizes the importance of a precision-based approach to nutrient therapy, where genetic (nutrigenomics ) and epigenetic factors (nutrigepigenetics ) guide personalized nutritional interventions (1), (2)

Key Concepts: Nutritional Pharmacology vs. Nutripharmacology

Nutritional pharmacology studies the therapeutic application of nutrients, utilizing vitamins, minerals, and other essential nutrients at pharmacological doses to treat or prevent diseases. By bridging the fields of nutrition and pharmacology, it explores how nutrients interact with biological systems on cellular and molecular levels, offering a novel therapeutic approach distinct from traditional pharmaceuticals. Pharmaconutrition, an evolving subset, applies these principles in clinical settings, particularly for critically ill patients, where specific nutrients are administered at pharmacological doses to modulate immune function, reduce inflammation, and support recovery.

Dr. Paul Edmond Wischmeyer: Pioneering Nutritional Pharmacology in Critical Care at Duke University

In the preface of his 2010 book, PharmacoNutrition and Nutrition Therapy in Critical Illness, Dr. Paul Edmond Wischmeyer introduces the term nutritional pharmacology to define an innovative approach in critical care. Here, specific nutrients-such as amino acids and antioxidants-are used not only for nutritional support but as active therapeutic agents that modulate immune and cellular responses by activating protective pathways, with the potential to significantly enhance clinical outcomes. This concept highlights the crucial role of precise, evidence-based nutrition in the recovery of critically ill patients, offering a complementary strategy to traditional pharmacological interventions in intensive care.

The book advocates for a scientific and individualized approach to supplementation in critical care, where nutrients serve targeted therapeutic functions beyond basic needs. Key supplements include antioxidants (e.g., vitamin C, vitamin E, beta-carotene, selenium), omega-3 fatty acids (EPA, DHA), amino acids (glutamine, arginine, citrulline), probiotics, essential vitamins (D, B12, folate), trace minerals (zinc, copper, manganese), and agents like Coenzyme Q10 (CoQ10) and N-Acetylcysteine (NAC). Each serves distinct roles: antioxidants reduce oxidative stress, omega-3s provide anti-inflammatory support, amino acids support immune function and blood flow, and probiotics promote gut health.

Pharmaconutrition integrates these supplements as therapeutic agents, targeting physiological pathways to aid recovery from severe trauma, sepsis, or surgery. This precision-based adjunct to pharmacological interventions requires a careful, personalized assessment of each patient's unique needs. Healthcare professionals must consider potential interactions, side effects, and dosage, regularly adjusting treatments to align with the patient's evolving metabolic state.

In conclusion, pharmaconutrition addresses the metabolic demands of critically ill patients, serving as a complementary, personalized intervention that enhances recovery, particularly in surgical and ICU contexts. (3).

Pharmaconutrition in Clinical Practice

Pharmaconutrition involves the administration of specific nutrients as therapeutic agents, akin to drugs, particularly in surgical and intensive care settings. This approach is rooted in the principles of clinical pharmacology, molecular biology, and clinical research, aiming to optimize nutrient delivery to critically ill patients.

The article by Pierre et al. (2013) explores the concepts of both pharmaconutrition and immunonutrition, emphasizing how specific nutrients can be utilized as therapeutic agents to improve clinical outcomes in critically ill patients. Over the years, nutrition support has evolved from simply ensuring adequate nutrient delivery to exploring how individual nutrients can optimize immune function and promote cellular recovery. In this context, immunonutrition refers to the use of specialized diets enriched with nutrients known to modulate immune responses, such as glutamine, arginine, ω-3 fatty acids, and vitamin C. These immunonutrients, when administered in precise combinations, have shown promise in reducing infections, improving immune function, and supporting patient recovery, although the article notes that the exact contributions of individual nutrients can be challenging to determine due to complex interactions.

In addition to these immunomodulating nutrients, the article also highlights the role of micronutrients in pharmaconutrition, including vitamin C, which acts as a potent antioxidant and aids in collagen synthesis; selenium, which supports antioxidant enzymes and immune functions; and zinc and magnesium, both essential for immune function and inflammation control. The article further discusses nucleotides for their potential in enhancing immune response and maintaining intestinal barrier integrity, as well as prebiotics, probiotics, and synbiotics for their ability to improve gut health and maintain microbiota balance, which is critical for immune resilience. Although evidence supports the benefits of these nutrients in various patient subgroups, further research is needed to determine optimal dosing and nutrient combinations tailored to specific clinical scenarios in both pharmaconutrition and immunonutrition. (4)

Multifunctional Roles of Pharmacological Vitamin C

To further illustrate the multifunctional roles of pharmacological intravenous vitamin C, the following diagram provides an overview:

For years, I pondered the various pleiotropic and positive effects of pharmacological vitamin C, or pharmacological ascorbate, and sought a phrase or expression that could summarize the remarkable benefits this supplement or nutritional agent provides. After several attempts, I concluded that while it originates as a vitamin, once it surpasses one gram, it transforms into an enzymatic cofactor or a compound with distinct pharmacological actions. It serves as an electron donor, a pro-drug, an antioxidant, a prooxidant, and a chelating agent, among other roles. Notably, it can induce reactive hypoglycemia, as it competes with glucose-its structural twin-leading to false positives in various lab tests, such as guaiac tests and peripheral glucose readings. The phrase nutritional pharmacology came to mind, and upon researching it, I found that this term had already been described in 1980 by Dr. Gene Spiller.

Pharmaconutrition Strategies in COVID-19: An Overview

The article by Santos et al. (2020), "Pharmaconutrition in the Clinical Management of COVID-19: A Lack of Evidence-Based Research But Clues to Personalized Prescription," explores the potential application of pharmaconutrition as an adjunctive strategy in managing COVID-19. The authors note that while nutrients such as vitamin D, zinc, vitamin C, and omega-3 fatty acids have demonstrated immunomodulatory and anti-inflammatory properties, the evidence supporting their specific use in COVID-19 patients remains limited and largely speculative. These nutrients could, in theory, bolster immune function and mitigate the inflammatory response characteristic of severe COVID-19 cases, yet the lack of robust, evidence-based research presents a significant barrier to clinical implementation.

The article emphasizes the necessity of a personalized approach to pharmaconutrition, taking into account individual deficiencies, pre-existing conditions, and the severity of the disease. Given the heterogeneity of COVID-19 presentations, a one-size-fits-all prescription is unlikely to be effective. Santos et al. advocate for well-designed clinical trials to evaluate the efficacy and safety of these nutrients, as well as to determine optimal dosing regimens tailored to diverse patient profiles. Despite the theoretical benefits, the authors caution against the routine use of pharmaconutrition in COVID-19 management until more conclusive data are available, underscoring the need for further research in this nascent area of clinical nutrition. (5)

Concepts and Applications in Nutritional Pharmacology and Nutri-kinetics/Nutri-dynamics

The future perspectives of surgical and ICU nutrition and the emerging concepts of nutrient pharmacokinetics emphasize the precise administration of specific nutrients to optimize patient outcomes. These approaches are founded on principles of clinical pharmacology, molecular biology, and rigorous clinical research, aiming to deliver the right nutrients, in the right doses, at the right time, via the right routes.

Comparative Analysis

Below is a comparative analysis of surgical and ICU nutrition versus acute and chronic conditions in the context of nutritional pharmacology.

The convergent principles identified between allopathic and Orthomolecular medicine, suggesting that the foundational concepts of Orthomolecular medicine had already been inadvertently embedded within traditional Western medicine, particularly in critical care settings. This insightful observation underscores the value of integrating these two paradigms for enhanced educational and clinical outcomes. (6), (7)

Dr. Paul E. Wischmeyer, MD, a specialist in critical care, perioperative care, and nutrition, focuses on helping patients prepare for and recover from surgeries and serious illnesses through innovative interventions such as nutrition and exercise. Inspired by his personal experience as a patient, having undergone 27 surgeries and multiple hospitalizations due to a gastrointestinal illness, Dr. Wischmeyer applies integrative and personalized strategies to improve patient outcomes. He is also dedicated to educating patients and caregivers on the importance of preparation and recovery, emphasizing how these factors can significantly enhance quality of life. As he states, "My unique expertise focuses on utilizing innovative and integrative interventions to improve the lives of patients before and after illness" (8)

Similarities in Nutritional Pharmacology and Nutri-kinetics/Nutri-dynamics

Precision in Nutrient Administration

• Surgical and ICU Nutrition: Emphasis is placed on administering specific pharmaconutrients akin to drugs, ensuring optimal dosing and timing for critically ill patients.
• Nutri-kinetics and Nutri-dynamics: Focuses on delivering the right molecules in the correct chemical form and appropriate amounts to address biochemical disruptions in chronic and acute conditions.

Clinical and Molecular Research Integration

• Surgical and ICU Nutrition: Utilizes clinical pharmacology and molecular biology to derive evidence-based nutritional interventions.
• Nutri-kinetics and Nutri-dynamics: Applies pharmacokinetic and pharmacodynamic principles to understand and optimize nutrient administration.

Targeted Nutrient Delivery

• Surgical and ICU Nutrition: Tailored nutrient delivery to improve patient outcomes in surgery and critical care settings.
• Nutri-kinetics and Nutri-dynamics: Customized nutrient administration to enhance therapeutic effects and mitigate underlying biochemical disruptions.

Pleiotropic Effects and Triage Theory

In the realm of orthomolecular medicine, the term "pleiotropic effect" refers to the multifaceted actions of a single nutrient or molecule across different physiological pathways and tissues. These effects can manifest as either beneficial or detrimental, depending on various factors including dosage, administration method, individual health status, and the specific nutrient in question.

The "triage theory" proposes that micronutrient deficiencies cause insidious damage, accelerating age-associated chronic diseases. Ames' theory suggests that when micronutrient availability is limited, functions essential for short-term survival take precedence over those whose loss can be better tolerated. This leads to an increased risk of chronic diseases of aging Ames, B. N. (2006). Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. (9)

The triage theory has been applied to vitamin K and selenium, among other micronutrients, demonstrating that deficiencies in these micronutrients can cause insidious changes, culminating in age-associated chronic diseases. Vitamin K is essential for γ-carboxylation of proteins, and deficiency has been linked to diseases like osteoporosis and atherosclerosis. Selenium is crucial for selenoprotein synthesis, and deficiency has been associated with diseases like cancer and cardiovascular disease. Ames, B. N. (2006). (9)

Pleiotropic Effects of Vitamin C

Due to the increased inflammatory response and metabolic demand during infectious diseases, as well as their associations with low circulating vitamin C concentrations, vitamin C administration may be beneficial in combating a number of viral infections by increasing the production of α/β interferons and downregulating the production of pro-inflammatory cytokines. (10)

Pleiotropic Effects:

High-dose intravenous vitamin C has shown promise in reducing ischemia/reperfusion injury, oxidative stress, myocardial injury, and arrhythmias, and in improving neurological outcomes and survival rates. Preliminary sepsis studies further support its potential benefits. Given the strong evidence, a randomized controlled trial (RCT) is urgently needed to confirm the efficacy of this affordable and safe therapy Critical Care. (2018). (11)

The Transition from Nutritional Supplementation to Nutripharmacology

The clinical pictures of patients, especially in critical situations, demand pertinent, timely, and satisfactory care, which is why combined therapeutic schemes, including allopathic medicines and pharmacological nutrients, have been incorporated. The clinical challenge forces physicians to search for new alternatives or therapeutic strategies for the optimal well-being of patients and their families.

Key Concepts:

1. The Leap from Nutritional Supplementation to Nutripharmacology: This transition involves moving from traditional vitamin supplementation to the targeted use of pharmaconutrients to address specific clinical challenges.
2. Clinical Challenge and Innovation: Physicians are compelled by clinical challenges to seek new alternatives or therapeutic strategies for the optimal well-being of patients and their families, with compassion inherently involved in this pursuit.
3. Evolution of Nutritional Approaches: The field has evolved towards pharmaconutrition, immunonutrition, and nutripharmacology, recognizing that many chronic and acute conditions are associated with fundamental biochemical disruptions.
4. Pharmaconutrition and Immunonutrition: These involve the use of specific nutritional substrates that modulate immune and inflammatory pathways, administered at doses exceeding physiological levels to achieve therapeutic effects
5. Orthomolecular Medicine: Orthomolecular medicine aims to restore and maintain health through the administration of adequate amounts of substances that are normally present and needed in the body.
6. Critical Illness Management: This involves delivering adequate nutrients and energy to critically ill patients to maintain metabolic functions and limit complications related to underfeeding.

Orthomolecular Medicine and Pharmaconutrition

• Orthomolecular Medicine: Focuses on natural substances in optimal amounts to maintain health and treat disease.
• Pharmaconutrition: Integrates pharmacological principles with nutrition science, emphasizing the therapeutic use of nutrients.

Key Roles and Metabolic Functions of Pharmacological Vitamin C IV

1. Antioxidant and Pro-oxidant Effects:
   • Antioxidant: High-dose vitamin C acts as a powerful antioxidant, neutralizing reactive oxygen species (ROS) and protecting cells from oxidative damage. This is crucial for maintaining cellular health, especially under stress conditions like cancer Riordan Clinic. (12)
   • Pro-oxidant: Interestingly, at high concentrations, vitamin C can also act as a pro-oxidant by generating hydrogen peroxide (H₂O₂) in the extracellular space. This selective cytotoxicity is leveraged in cancer therapies, where it helps to induce apoptosis in cancer cells while sparing normal cells Riordan Clinic. (12)
2. Coenzymatic Factor:
   • Vitamin C serves as a coenzyme in various critical biochemical pathways. It is essential for the synthesis of collagen, which is vital for maintaining the structural integrity of tissues. Additionally, it plays a role in the synthesis of carnitine, necessary for fatty acid metabolism, and in the production of neurotransmitters, which are crucial for brain function and mood regulation Riordan Clinic. (12)
3. As an Electron Donor:
   • Vitamin C is integral in maintaining the redox state of cells, acting as an electron donor in numerous enzymatic reactions. This function is vital for processes like collagen synthesis and the regeneration of other antioxidants, such as vitamin E. (12)
4. Prodrug for Hydrogen Peroxide:
   • In cancer therapy, pharmacological doses of vitamin C act as a prodrug for hydrogen peroxide, selectively enhancing the oxidative stress within cancer cells, leading to their destruction without harming normal cells. Pharmacological (12)
5. Immune Support:
   • Vitamin C also functions as an immune nutrient, enhancing the body's defense mechanisms. It has been shown to support immune function by stimulating the production and function of white blood cells, improving resistance to infections, and reducing the duration and severity of colds. (12)
6. Detoxification:
   • Acting as a mild chelator, vitamin C helps to detoxify the body by binding to heavy metals like lead and mercury, aiding in their excretion from the body. (12)

Effects of Different Pharmaconutrients on Metabolic Response, Inflammation, Immune Response, and Healing in Situations of Injury or Aggression

The following table outlines the effects of various pharmaconutrients on key metabolic and immune functions during injury or aggression:

Glutamine is a crucial amino acid for tissue protection, anti-inflammatory action, immune regulation, and more. Its levels decrease in stress situations, leading to negative effects, making it semi-essential for critically ill patients.

Dietary fiber, either insoluble (mechanical effect) or soluble (fermentable, producing SCFAs), has different roles. Insoluble fiber can pose risks like obstruction, while soluble fiber can reduce enteral nutrition-associated diarrhea.

The intestinal flora is crucial for protection against infections and maintaining barrier functions. Probiotics (live beneficial microorganisms) and prebiotics (fermentable fiber) can help restore intestinal flora balance.

Meta-analyses have shown that diets enriched with pharmaconutrients decrease infectious complications, hospital stay, and mechanical ventilation duration, though interpretation remains controversial due to study heterogeneity. (13)

Metabolome and Exposome

The metabolome represents the complete set of metabolites present within an organism, providing insights into metabolic processes and disease states. The exposome encompasses all environmental exposures, including diet, that an individual encounters throughout their life. Integrating metabolomics and exposomics allows for a comprehensive understanding of how external factors and metabolic changes influence health and disease.

The comprehensive range of environmental exposures, known as the exposome, has a profound influence on human health. Addressing the adverse outcomes of these exposures requires targeted interventions. Nutritional pharmacology and toxicology focus on correcting metabolic disruptions caused by environmental factors, facilitating precision public health strategies and the formulation of customized nutrient 'cocktails'. (14)

Metabolic Optimization

Metabolic optimization involves fine-tuning metabolic processes to achieve optimal physiological function and health. This can be achieved through personalized nutrition, exercise, and lifestyle modifications. By leveraging advancements in metabolomics and nutrigenomics, healthcare providers can create customized strategies to enhance metabolic health and prevent metabolic disorders. (15)

Pharmacological Ascorbate (IV Vitamin C) and Other Key Micronutrients

Pharmacological ascorbate (IV vitamin C) and other key micronutrients such as antioxidants, pro-oxidants, coenzymatic factors, and electron donors have been increasingly recognized for their potential therapeutic benefits in various clinical scenarios.

Pharmacological Ascorbate

Pharmacological ascorbate, at millimolar concentrations in plasma, has shown significant promise in cancer treatment, particularly due to its ability to selectively induce oxidative stress in cancer cells. This is achieved through the extracellular generation of hydrogen peroxide (H₂O₂), which selectively kills cancer cells while sparing normal cells. The underlying mechanism exploits the differential catalase activity between cancer and normal cells; cancer cells exhibit lower catalase activity, making them more vulnerable to the accumulation of H₂O₂, leading to DNA damage and subsequent cell death. In contrast, normal cells, with higher catalase levels, are able to neutralize H₂O₂, thus avoiding oxidative damage. Moreover, recent studies have demonstrated that pharmacological ascorbate enhances the radiosensitivity of tumors, amplifying the effects of radiation therapy by increasing oxidative stress in cancerous tissues. This dual action of ascorbate-inducing oxidative damage and enhancing radiosensitivity-makes it a potent adjuvant in cancer therapies, leveraging biochemical vulnerabilities of cancer cells for more targeted and effective treatment strategies. (16)

Key Micronutrients

1. Prodrugs and Coenzymatic Factors:

Prodrugs like NAD+ precursors are essential for cellular metabolism and energy production. They enhance the body's ability to produce ATP, thus supporting various physiological functions.

Coenzymatic factors, such as vitamins B1, B2, and B6, are crucial for enzymatic reactions that maintain cellular metabolism and repair. (17), (18), (19)

2. Antioxidants and Pro-oxidants:

Antioxidants like glutathione and vitamin E protect cells from oxidative stress by neutralizing free radicals. However, in pharmacological doses, some agents like vitamin C can act as pro-oxidants (20), particularly in cancer therapy, to induce targeted oxidative stress in tumor cells.

In (Potdar et al., 2018) Intravenous (IV) pharmacological doses of Vitamin C have demonstrated a synergistic effect with key antioxidants such as glutathione, CoQ10, and alpha-lipoic acid. This synergy enhances the recycling of these antioxidants, helping maintain cellular redox balance and protecting against oxidative stress. Vitamin C plays a critical role in restoring the oxidized forms of these antioxidants, allowing them to continue neutralizing reactive oxygen species (ROS). The recycling of antioxidants is crucial in the prevention of oxidative stress-related diseases, including cardiovascular and neurodegenerative disorders. This mechanism highlights the importance of combined antioxidant therapies for supporting cellular health and preventing chronic disease progression (21), (22), (23), (24)

Electron Donors:

Micronutrients that act as electron donors, such as vitamin C and coenzyme Q10, play a pivotal role in the electron transport chain and mitochondrial function. They support energy production and reduce oxidative damage. (25), (26), (27)

Clinical Applications

The combined use of key micronutrients, including antioxidants such as glutathione, CoQ10, and pro-oxidants like pharmacological doses of Vitamin C, has demonstrated significant potential in improving patient outcomes in critical care and surgical settings. These micronutrients act as electron donors, which help neutralize oxidative stress and mitigate biochemical dysfunction. In particular, antioxidants support the body's defense against reactive oxygen species, while the recycling of antioxidants, such as glutathione, helps maintain redox balance. In critically ill patients, this supplementation has shown promise in reducing drug-induced nutrient depletion and enhancing overall health and recovery. Recent studies suggest that the administration of multiple antioxidants and micronutrients may provide superior clinical outcomes compared to isolated supplementation of individual compounds (Heyland et al., 2005; Canadian Critical Care Trials Group, 2006). (28), (29)

Compassion in Healthcare

Frampton et al. (2013) emphasize the pivotal role of compassion in delivering patient-centered care, particularly in hospital and critical care settings. The article argues that compassion is not just a desirable trait but a fundamental cornerstone of effective healthcare delivery. Compassion involves understanding patients' individual needs, fears, and preferences, which contributes to the creation of a more empathetic and personalized care experience. The authors highlight the importance of integrating compassion into the daily practices of healthcare professionals, including nurses, doctors, and hospital staff, as it significantly enhances patient outcomes.

The study further explores how organizational support is crucial in promoting compassionate care. Healthcare institutions that invest in training and systems to encourage empathy and understanding see improved clinical outcomes and higher patient satisfaction. Compassionate care also fosters trust and rapport between patients and providers, ultimately enhancing the healing process and promoting better health outcomes, particularly in critical care and intra-hospital environments. By embedding compassion into the framework of healthcare delivery, both the emotional well-being of patients and the professional satisfaction of healthcare workers are enhanced, creating a more sustainable and effective healthcare system. (30)

Compassion remains a cornerstone of effective healthcare delivery. It involves understanding patients' needs, fears, and preferences, and providing care that is empathetic and patient-centered. In the context of nutritional interventions, compassion ensures that recommendations are tailored to individual circumstances, promoting adherence and positive health outcomes.

Conclusions and Perspectives

The current landscape of nutritional science and medicine is characterized by rapid advancements and an increasing recognition of the importance of personalized nutrition. Research continues to unveil the complex interactions between diet, genetics, and health, paving the way for innovative approaches to disease prevention and management. Fields such as nutriepigenetics, nutrigenomics, metabolomics, and exposomics are pivotal in enhancing our understanding of the biochemical and epigenetic alterations linked to numerous health challenges. These disciplines facilitate precise diagnostics, proactive prevention, and effective treatment of the myriad clinical issues encountered daily.

In this context, compassion remains a cornerstone of effective healthcare delivery, particularly in Intensive Care Units (ICUs) and clinics dealing with complex health challenges. Understanding patients' needs, fears, and preferences allows healthcare professionals to provide empathetic, patient-centered care. This compassionate approach is crucial when implementing nutritional interventions, ensuring that recommendations are tailored to individual circumstances, which promotes adherence and fosters positive health outcomes.

Moreover, it is essential that metanutritional treatments be individualized, as the response to various health challenges is inherently unique to each patient. The integration of pharmaconutrients in elevated doses or megadoses, along with relevant metanutritional amounts of nutrient agents, presents significant opportunities to effectively resolve various health conditions, often without lasting sequelae. The convergence of nutritional pharmacology with various pharmaconutrients has shown effectiveness across multiple settings, including inpatient care and diverse clinics.

Looking forward, the future of nutritional pharmacology, nutritional supplementation, orthomolecular medicine, and related fields is promising. Emphasis on personalized, evidence-based interventions will continue to grow, transforming healthcare into a more precise and effective practice. As researchers and clinicians, our responsibility is to stay at the forefront of these developments, ensuring that we harness these advancements to improve patient care and health outcomes globally.

Future Directions:

1. Integration of Nutritional Pharmacology and Traditional Medicine: Combining the strengths of both approaches to maximize patient outcomes.
2. Personalized Nutrition: Leveraging advancements in metabolomics and nutrigenomics to create customized health strategies.
3. Enhanced Research and Evidence-Based Practice: Increasing the body of evidence supporting the efficacy of nutritional interventions in various clinical settings.
4. Compassionate Care: Ensuring patient-centered approaches that take into account individual needs and preferences.

By bridging the gap between nutritional pharmacology and key pharmanonutrients, we can create a more holistic and effective approach to healthcare that benefits both providers and patients.

To APENDIX I - Key Micronutrients in Hospital Settings
To APENDIX II - The Latest Trends in Nutritional Pharmacology for 2024

References:

1. Martinez Méndez J. IV Pharmacological Ascorbate: A Misunderstood Nutripharmacologic Medical Therapy. Orthomolecular Medicine News Service. Available in : orthomolecular.org https://orthomolecular.org/resources/omns/v19n44.shtml

2. Bland J. The Future of Nutritional Pharmacology. Alternative Therapies in Health and Medicine [Internet]. 2008 [cited 2023 Oct 27]. Disponible en: researchgate.net https://www.researchgate.net/publication/23246353_The_future_of_nutritional_pharmacology

3. Wischmeyer, P. E. (2010). PharmacoNutrition and Nutrition Therapy in Critical Illness, An Issue of Critical Care Clinics. Volume 26-3. Elsevier.

4. Wischmeyer PE. Pharmaconutrition: Review of Physiological Mechanisms [Internet]. [cited 2023 Oct 27]. Available from: researchgate.net https://www.researchgate.net/publication/256689971_Pharmaconutrition_Review_Physiological_Mechanisms

5. Santos HO, et al. Pharmaconutrition in the Clinical Management of COVID-19: A Lack of Evidence-Based Research But Clues to Personalized Prescription. J Pers Med. 2020;10(4):145. doi: 10.3390/jpm10040145. https://www.mdpi.com/2075-4426/10/4/145

6. Wischmeyer P. Nutritional Pharmacology in Surgery and Critical Care: "You Must Unlearn What You Have Learned". Curr Opin Anaesthesiol. 2011 Aug;24(4):381-8. doi: 10.1097/ACO.0b013e32834872b6. PMID: 21734486. https://journals.lww.com/co-anesthesiology/abstract/2011/08000/nutritional_pharmacology_in_surgery_and_critical.5.aspx

7. Gonzalez M, Miranda-Massari J, Duconge J, Martinez Méndez J, Olalde J, Gonzalez M, Berdiel M, Lozada J, Smith R, Saul A. New Concepts for Understanding Nutrient Pharmacokinetics: Nutri-kinetics and Nutri-dynamics. 2023 [Internet]. Available from: researchgate.net https://www.researchgate.net/publication/369033898_New_Concepts_for_Understanding_Nutrient_Pharmacokinetics_Nutri-kinetics_and_Nutri-dynamics

8. Wischmeyer PE. Duke Health [Internet]. 2024 [cited 2023 Oct 27]. Available from:dukehealth.org https://www.dukehealth.org/find-doctors-physicians/paul-e-wischmeyer-md

9. Ames BN. Low Micronutrient Intake May Accelerate the Degenerative Diseases of Aging Through Allocation of Scarce Micronutrients by Triage. Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17589-94. doi: 10.1073/pnas.0608757103. PMID: 17101959; PMCID: PMC1693790. Available from:pmc.ncbi.nlm.nih.gov https://pmc.ncbi.nlm.nih.gov/articles/PMC1693790/

10. Riordan HD, et al. Antiviral Mechanisms of Vitamin C: A Short Communication Consensus Report [Internet]. 2020 [cited 2023 Oct 27]. Disponible en: isom.ca https://isom.ca/article/antiviral-mechanisms-of-vitamin-c-a-short-communication-consensus-report/

11. Critical Care. (2018). Making sense of early high-dose intravenous vitamin C in ischemia/reperfusion injury, 22(1):70. DOI: 10.1186/s13054-018-1996-y. https://ccforum.biomedcentral.com/articles/10.1186/s13054-018-1996-y

12. Gonzalez MJ, Miranda-Massari JR, Jorge R. New insights on pharmacological Vitamin C: Antioxidant and pro-oxidant effects, coenzymatic roles, mild chelation, electron donor function, and hydrogen peroxide generation in cancer therapy. Springer, 2014. Available from: jeffreydachmd.com https://jeffreydachmd.com/wp-content/uploads/2017/06/New-Insights-vitamin-C-and-Cancer-Gonzalez-Michael-Springer-2014.pdf

13. Vaquerizo Alonso, C., et al. (2020). Recommendations for specialized nutritional-metabolic management of the critical patient. Med Intensiva (Engl Ed), 44 Suppl 1:1-14. Available from: DOI: 10.1016/j.medine.2019.12.002 https://www.sciencedirect.com/science/article/abs/pii/S2173572720300400?via%3Dihub

14. Blake R Rushing, et al. (2023). The exposome and nutritional pharmacology and toxicology: a new application for metabolomics. Exposome, 3(1), osad008. DOI: 10.1093/exposome/osad008. https://academic.oup.com/exposome/article/3/1/osad008/7444013

15. Lagoumintzis G, Afratis NA and Patrinos GP (2024) Editorial: Nutrigenomics and personalized nutrition: advancing basic, clinical, and translational research. Front. Nutr. 11:1435475. doi: 10.3389/fnut.2024.1435475 https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2024.1435475/full

16. Mehdi Z, Petronek MS, Stolwijk JM, et al. Utilization of pharmacological ascorbate in cancer therapy. Int J Mol Sci. 2021;22(19):10880. Available from:mdpi.com https://www.mdpi.com/1422-0067/22/19/10880

17. Pramono AA, Rather GM, Herman H, Lestari K. NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview. Biomolecules. 2020. Available from: Link https://www.mdpi.com/2218-273X/10/3/358/

18. Navas LE, Carnero A. Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer. Cells. 2022;11(17):2627. Available from: Link https://www.mdpi.com/2073-4409/11/17/2627/

19. Piquereau J, Boitard SE, Ventura-Clapier R, et al. Metabolic Therapy of Heart Failure: Is There a Future for B Vitamins? International Journal of Molecular Sciences. 2021. Link https://www.mdpi.com/1422-0067/23/1/30/

20. Kumar V, Khan AA, Tripathi A, Dixit PK, Bajaj UK. Role of oxidative stress in various diseases: Relevance of dietary antioxidants. J Phytopharm, 2015. Available from: researchgate.net https://www.researchgate.net/profile/Vinay-Kumar-44/publication/277477072_Role_of_oxidative_stress_in_various_diseases_Relevance_of_dietary_antioxidants/links/556bd32b08aec22683037df0/Role-of-oxidative-stress-in-various-diseases-Relevance-of-dietary-antioxidants.pdf

21. Potdar A, Dantuma D, Preuss C, Pathak Y. Pharmacology and Pharmacokinetics of Natural Antioxidants in the Human Body. In: Antioxidant Nutraceuticals. Taylor & Francis; 2018. Available from: taylorfrancis.com https://www.taylorfrancis.com/chapters/edit/10.1201/9781315121024-16/pharmacology-pharmacokinetics-natural-antioxidants-human-body-aishwarya-potdar-danielle-dantuma-charles-preuss-yashwant-pathak

22. Carr AC, Frei B. Toward a New Recommended Dietary Allowance for Vitamin C for Humans. Am J Clin Nutr. 1999;69(6):1086-1093. Available from: Link https://www.sciencedirect.com/science/article/pii/S0002916522044136?via%3Dihub

23. Hemilä H, Chalker E. Vitamin C Can Shorten the Length of Stay in the ICU: A Meta-Analysis. Nutrients. 2020;12(12):3799. Available from: Link https://www.mdpi.com/2072-6643/11/4/708

24. Kang JS. Vitamin intervention for cytokine storm in the patients with coronavirus disease 2019. MedComm (2020). 2020 Jun;1(1):81-83. Available from: Link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323139/

25. Falasca, A., et al. (2003). "Mitochondrial production of oxygen radical species and the role of Coenzyme Q as an antioxidant". Available from: Link https://www.researchgate.net/profile/Anna-Falasca/publication/10791343_Mitochondrial_Production_of_Oxygen_Radical_Species_and_the_Role_of_Coenzyme_Q_as_an_Antioxidant/links/02e7e5278bab9063b6000000/Mitochondrial-Production-of-Oxygen-Radical-Species-and-the-Role-of-Coenzyme-Q-as-an-Antioxidant.pdf

26. Kucharská, J. (2008). "Vitamins in mitochondrial function". En Mitochondrial Medicine: Mitochondrial Metabolism, Diseases, Diagnosis and Therapy (Springer). Available from: Link https://link.springer.com/chapter/10.1007/978-1-4020-6714-3_21

27. Napolitano, G., Fasciolo, G., & Venditti, P. (2021). "Mitochondrial management of reactive oxygen species". Antioxidants. Available from: Link https://www.mdpi.com/2076-3921/10/11/1824/

28. Heyland DK, Dhaliwal R, Suchner U, Berger MM. Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med. 2005. Available from: academia.edu https://www.academia.edu/50146208/Antioxidant_nutrients_a_systematic_review_of_trace_elements_and_vitamins_in_the_critically_ill_patient?sm=b

29. Canadian Critical Care Trials Group. Reducing deaths due to oxidative stress: rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically ill patients. Proc Nutr Soc. 2006. Available from: cambridge.org https://www.cambridge.org/core/services/aop-cambridge-core/content/view/4B68F09E704FCF891A29E4550B23CC01/S0029665106000334a.pdf/reducing_deaths_due_to_oxidative_stress_the_redoxs_study_rationale_and_study_design_for_a_randomized_trial_of_glutamine_and_antioxidant_supplementation_in_criticallyill_patients.pdf

30. Frampton SB, Guastello S, et al. Compassion as the foundation of patient-centered care: the importance of compassion in action. Journal of Comparative Effectiveness Research. 2013. Available from: becarispublishing.com https://becarispublishing.com/doi/pdf/10.2217/cer.13.54?

Key Micronutrients in Hospital Settings

• Glutamine: 30 g
• Vitamin C: 25 g
• Arginine: 20 g
• Magnesium: 4 g
• Omega-3 Fatty Acids: 3 g
• Zinc: 30 mg
• Selenium: 0.4 mgrs to 4 mgrs

References:

1. Vaquerizo Alonso, C., et al. (2020). Recommendations for specialized nutritional-metabolic management of the critical patient. Med Intensiva (Engl Ed), 44 Suppl 1:1-14. Available from: DOI: 10.1016/j.medine.2019.12.002.

2. Santos, H. O., et al. (2020). Pharmaconutrition in the Clinical Management of COVID-19: A Lack of Evidence-Based Research But Clues to Personalized Prescription. Journal of Personalized Medicine, 10(4): 145. Available from: DOI: 10.3390/jpm10040145.

3. Wischmeyer, P. (2011). Nutritional pharmacology in surgery and critical care: 'you must unlearn what you have learned'. Curr Opin Anaesthesiol, 24(4):381-8. Available from: DOI: 10.1097/ACO.0b013e3283470215.

4. Rude, R. K. (2012). Magnesium deficiency: A cause of heterogeneous disease in clinical medicine. Journal of the American College of Nutrition, 31(2), 132S-138S. Available from: DOI: 10.1080/07315724.2012.10719958.

5. Calder, P. C. (2015). Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochemical Society Transactions, 43(5), 813-820. Available from: DOI: 10.1042/BST20150155.

• Personalized Nutrition: Driven by advances in genetic testing and AI, enabling customized dietary recommendations.
• Gut-Brain Health: Focusing on how gut health influences mental well-being, often through probiotics and adaptogens.
• Sustainable Eating: Emphasizing plant-based diets and eco-friendly food production.
• Functional Ingredients for Wellness: Using ingredients like ashwagandha and omega-3s to support mental and physical health.

References:

1. New Nutrition Business. "Functional Foods for Mental Health and Wellness". Available at: New Nutrition Business​ https://www.new-nutrition.com/

2. Carvalho NM, Oliveira DL, Costa CM, Pintado ME. Strategies to assess the impact of sustainable functional food ingredients on gut microbiota. Foods. 2023. Available from: mdpi.com https://www.mdpi.com/2304-8158/12/11/2209

Nutritional Medicine is Orthomolecular Medicine

Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org

Find a Doctor

To locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml

The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.

Editorial Review Board:

Albert G. B. Amoa, MB.Ch.B, Ph.D. (Ghana)
Seth Ayettey, M.B., Ch.B., Ph.D. (Ghana)
Ilyès Baghli, M.D. (Algeria)
Barry Breger, M.D. (Canada)
Ian Brighthope, MBBS, FACNEM (Australia)
Gilbert Henri Crussol, D.M.D. (Spain)
Carolyn Dean, M.D., N.D. (USA)
Ian Dettman, Ph.D. (Australia)
Susan R. Downs, M.D., M.P.H. (USA)
Ron Ehrlich, B.D.S. (Australia)
Hugo Galindo, M.D. (Colombia)
Gary S. Goldman, Ph.D. (USA)
William B. Grant, Ph.D. (USA)
Claus Hancke, MD, FACAM (Denmark)
Patrick Holford, BSc (United Kingdom)
Ron Hunninghake, M.D. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Dwight Kalita, Ph.D. (USA)
Felix I. D. Konotey-Ahulu, M.D., FRCP (Ghana)
Peter H. Lauda, M.D. (Austria)
Fabrice Leu, N.D., (Switzerland)
Alan Lien, Ph.D. (Taiwan)
Homer Lim, M.D. (Philippines)
Stuart Lindsey, Pharm.D. (USA)
Pedro Gonzalez Lombana, M.D., Ph.D. (Colombia)
Victor A. Marcial-Vega, M.D. (Puerto Rico)
Juan Manuel Martinez, M.D. (Colombia)
Mignonne Mary, M.D. (USA)
Joseph Mercola, D.O. (USA)
Dr.Aarti Midha M.D., ABAARM (India)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Karin Munsterhjelm-Ahumada, M.D. (Finland)
Sarah Myhill, MB, BS (United Kingdom)
Tahar Naili, M.D. (Algeria)
Zhiyong Peng, M.D. (China)
Isabella Akyinbah Quakyi, Ph.D. (Ghana)
Selvam Rengasamy, MBBS, FRCOG (Malaysia)
Jeffrey A. Ruterbusch, D.O. (USA)
Gert E. Schuitemaker, Ph.D. (Netherlands)
Thomas N. Seyfried, Ph.D. (USA)
Han Ping Shi, M.D., Ph.D. (China)
T.E. Gabriel Stewart, M.B.B.CH. (Ireland)
Jagan Nathan Vamanan, M.D. (India)

Andrew W. Saul, Ph.D. (USA), Founding Editor
Richard Cheng, M.D., Ph.D. (USA), Editor-In-Chief
Associate Editor: Robert G. Smith, Ph.D. (USA)
Editor, Japanese Edition: Atsuo Yanagisawa, M.D., Ph.D. (Japan)
Editor, Chinese Edition: Richard Cheng, M.D., Ph.D. (USA)
Editor, Norwegian Edition: Dag Viljen Poleszynski, Ph.D. (Norway)
Editor, Arabic Edition: Moustafa Kamel, R.Ph, P.G.C.M (Egypt)
Editor, Korean Edition: Hyoungjoo Shin, M.D. (South Korea)
Editor, Spanish Edition: Sonia Rita Rial, PhD (Argentina)
Editor, German Edition: Bernhard Welker, M.D. (Germany)
Associate Editor, German Edition: Gerhard Dachtler, M.Eng. (Germany)
Assistant Editor: Michael Passwater (USA)
Contributing Editor: Thomas E. Levy, M.D., J.D. (USA)
Contributing Editor: Damien Downing, M.B.B.S., M.R.S.B. (United Kingdom)
Contributing Editor: W. Todd Penberthy, Ph.D. (USA)
Contributing Editor: Ken Walker, M.D. (Canada)
Contributing Editor: Michael J. Gonzalez, N.M.D., Ph.D. (Puerto Rico)
Technology Editor: Michael S. Stewart, B.Sc.C.S. (USA)
Associate Technology Editor: Robert C. Kennedy, M.S. (USA)
Legal Consultant: Jason M. Saul, JD (USA)

Comments and media contact: editor@orthomolecular.org OMNS welcomes but is unable to respond to individual reader emails. Reader comments become the property of OMNS and may or may not be used for publication.

To Subscribe at no charge: http://www.orthomolecular.org/subscribe.html

To Unsubscribe from this list: http://www.orthomolecular.org/unsubscribe.html